Atty Fees Sought For $108M Cooley Malpractice Suit In NJ
Managers of a pharmaceutical company sold to pharma giant Lupin in 2017 have filed a lawsuit in Delaware Chancery Court seeking to have the companies advance them legal fees in connection...To view the full article, register now.
Already a subscriber? Click here to view full article